[{"NetIncomeLoss_3_Q3_USD":-18931000.0,"RepaymentsOfSecuredDebt_3_Q3_USD":88000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q3_USD":13305000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":28281000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":9823000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":17700429.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":19112797.0,"LiabilitiesNoncurrent_0_Q3_USD":42821000.0,"RestrictedCashCurrent_0_Q3_USD":1369000.0,"InterestPaidNet_3_Q3_USD":1218000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":67000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-10637000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":30.97,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":0.0,"ProceedsFromRelatedPartyDebt_3_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q3_shares":0.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":70000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-94000.0,"GoodwillForeignCurrencyTranslationGainLoss_3_Q3_USD":394000.0,"AssetsCurrent_0_Q3_USD":161378000.0,"LongTermDebtCurrent_0_Q3_USD":129000.0,"IncreaseDecreaseInAccountsAndNotesReceivable_3_Q3_USD":389000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":12241000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":4566000.0,"RepaymentsOfRelatedPartyDebt_3_Q3_USD":25000000.0,"SellingAndMarketingExpense_3_Q3_USD":22421000.0,"SellingAndMarketingExpense_1_Q3_USD":9237000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":450606.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":348000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q3_USD":1259000.0,"CommonStockSharesIssued_0_Q3_shares":19554621.0,"IncreaseDecreaseInOtherOperatingCapitalNet_3_Q3_USD":24000.0,"Liabilities_0_Q3_USD":68568000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":1077000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":30.97,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":3839000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-24000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-558000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-312000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-122000.0,"AccountsReceivableNetCurrent_0_Q3_USD":17064000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"CommonStockValue_0_Q3_USD":5000.0,"NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_3_Q3_USD":-18373000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":5696000.0,"OperatingLeaseLiability_0_Q3_USD":332000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3_Q3_shares":4556.0,"ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_3_Q3_USD":0.0,"ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1_Q3_USD":0.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":1819000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q3_USD":909000.0,"IncomeLossFromContinuingOperations_3_Q3_USD":-18931000.0,"IncomeLossFromContinuingOperations_1_Q3_USD":-4539000.0,"IncreaseDecreaseInInventories_3_Q3_USD":12340000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-18931000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-4539000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-18861000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-4633000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":155000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":88372000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":46748000.0,"Assets_0_Q3_USD":308004000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":335000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":70207000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":70000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-94000.0,"Goodwill_0_Q3_USD":60148000.0,"InterestIncomeExpenseNet_3_Q3_USD":-2788000.0,"InterestIncomeExpenseNet_1_Q3_USD":-1010000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-18373000.0,"CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_0_Q3_USD":89741000.0,"LiabilitiesCurrent_0_Q3_USD":25747000.0,"AccountsPayableCurrent_0_Q3_USD":6904000.0,"NonoperatingIncomeExpense_3_Q3_USD":-4919000.0,"NonoperatingIncomeExpense_1_Q3_USD":-2041000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":89741000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":2065000.0,"CommonStockSharesOutstanding_0_Q3_shares":19554621.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1629000.0,"GrossProfit_3_Q3_USD":39913000.0,"GrossProfit_1_Q3_USD":17639000.0,"AdditionalPaidInCapital_0_Q3_USD":387117000.0,"PaymentsToAcquireIntangibleAssets_3_Q3_USD":0.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q3_USD":30.97,"NotesAndLoansReceivableNetCurrent_0_Q3_USD":476000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":52600.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":48898000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"LongTermNotesAndLoans_0_Q3_USD":1078000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":29009000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":24275000.0,"NetIncomeLoss_1_Q3_USD":-4539000.0,"LongTermDebtNoncurrent_0_Q3_USD":1078000.0,"CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_3_Q3_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":17714000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-147753000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0003,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":215000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_0_Q3_USD":0.0,"CommonStockSharesAuthorized_0_Q3_shares":50000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":52154000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":22205000.0,"OperatingIncomeLoss_3_Q3_USD":-14012000.0,"OperatingIncomeLoss_1_Q3_USD":-2498000.0,"InventoryNet_0_Q3_USD":52032000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":52737000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":30.97,"LiabilitiesAndStockholdersEquity_0_Q3_USD":308004000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":4772000.0,"ImpairmentOfIntangibleAssetsFinitelived_3_Q3_USD":0.0,"ImpairmentOfIntangibleAssetsFinitelived_1_Q3_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_3_Q3_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_1_Q3_USD":0.0,"OperatingExpenses_3_Q3_USD":53925000.0,"OperatingExpenses_1_Q3_USD":20137000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.07,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.24,"OtherLiabilitiesNoncurrent_0_Q3_USD":332000.0,"OtherLiabilitiesCurrent_0_Q3_USD":2022000.0,"StockholdersEquity_0_Q3_USD":239436000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":6448000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":208000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":13472.0,"DebtLongtermAndShorttermCombinedAmount_0_Q3_USD":1207000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":3223000.0,"ClassOfWarrantOrRightOutstanding_0_Q3_shares":404.0,"Ticker":"KIDS","CIK":"1425450","name":"ORTHOPEDIATRICS CORP","OfficialName":"OrthoPediatrics Corp. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"1000731682.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]